These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2081089)

  • 41. Drugs of choice for cancer chemotherapy.
    Med Lett Drugs Ther; 1991 Mar; 33(840):21-8. PubMed ID: 2002782
    [No Abstract]   [Full Text] [Related]  

  • 42. Evidence for recruitment and synchronization in leukemia and solid tumors.
    Mauer AM; Murphy SB; Hayes FA
    Cancer Treat Rep; 1976 Dec; 60(12):1841-4. PubMed ID: 1026338
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reanalysis of cancer drugs: old drugs, new tricks.
    Vande Woude GF; Kelloff GJ; Ruddon RW; Koo HM; Sigman CC; Barrett JC; Day RW; Dicker AP; Kerbel RS; Parkinson DR; Slichenmyer WJ
    Clin Cancer Res; 2004 Jun; 10(11):3897-907. PubMed ID: 15173099
    [No Abstract]   [Full Text] [Related]  

  • 44. Modeling and optimization of combined cytostatic and cytotoxic cancer chemotherapy.
    Villasana M; Ochoa G; Aguilar S
    Artif Intell Med; 2010 Nov; 50(3):163-73. PubMed ID: 20620035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A qualitative approach to cell growth modeling and simulation for cancer chemotherapy.
    Gaglio S; Giacomini M; Nicolini C; Ruggiero C
    IEEE Trans Biomed Eng; 1991 Apr; 38(4):386-9. PubMed ID: 1855803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potential innovations in scheduling of cancer chemotherapy.
    Norton L; Day R
    Important Adv Oncol; 1991; ():57-72. PubMed ID: 1869282
    [No Abstract]   [Full Text] [Related]  

  • 47. How long the adjuvant treatment should be protracted.
    Cerný V
    Arch Geschwulstforsch; 1978; 48(7):636-43. PubMed ID: 736744
    [No Abstract]   [Full Text] [Related]  

  • 48. Improving drug penetration to curb tumor drug resistance.
    Marcucci F; Corti A
    Drug Discov Today; 2012 Oct; 17(19-20):1139-46. PubMed ID: 22706017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological principles of brain tumor chemotherapy.
    Levin VA
    Adv Neurol; 1976; 15():315-25. PubMed ID: 779423
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The application of mathematical modelling to aspects of adjuvant chemotherapy scheduling.
    Gaffney EA
    J Math Biol; 2004 Apr; 48(4):375-422. PubMed ID: 15052504
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cytostatic chemotherapy and sensitivity tests (oncobiograms) (author's transl)].
    Matthias M; Matthes T; Tanneberger S
    Z Erkr Atmungsorgane; 1975 Feb; 142(2):132-9. PubMed ID: 1226879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Resistance testing of malignant tumors. Possibility of analysis of the clinical development of secondary resistance to cytostatic drugs].
    Possinger K; Hartenstein R; Ehrhart H
    MMW Munch Med Wochenschr; 1978 May; 120(21):725-8. PubMed ID: 306551
    [No Abstract]   [Full Text] [Related]  

  • 53. International workshop on surgical adjuvant antineoplastic chemotherapy in solid tumors. Conclusions and recommendations of the workshop. Principal problems of surgical adjuvant chemotherapy.
    Goldin A; Ghione M
    Arch Geschwulstforsch; 1978; 48(7):605-8. PubMed ID: 736739
    [No Abstract]   [Full Text] [Related]  

  • 54. Neo-endocrinochemotherapy: a novel approach for enhancing chemotherapeutic efficacy in clinic?
    Huang J; Ji G; Xing L; Li H; Wang Z; Ren G; Wu K; Kong L
    Med Hypotheses; 2013 Apr; 80(4):441-6. PubMed ID: 23375412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer chemotherapy.
    Cullen MH
    Practitioner; 1976 Oct; 217(1300 SPEC NO):617-23. PubMed ID: 790368
    [No Abstract]   [Full Text] [Related]  

  • 56. Q&A: Geoffrey Shapiro on phase I drug trials. Spoke with Suzanne Rose.
    Shapiro G
    Cancer Discov; 2013 Oct; 3(10):1089. PubMed ID: 24124216
    [No Abstract]   [Full Text] [Related]  

  • 57. Use of biguanides to improve response to chemotherapy.
    Sandulache VC; Yang L; Skinner HD
    Methods Mol Biol; 2014; 1165():3-9. PubMed ID: 24839014
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Implications of certain cell kinetic and biological parameters for preoperative chemotherapy.
    Hill BT
    Recent Results Cancer Res; 1986; 103():41-53. PubMed ID: 3526475
    [No Abstract]   [Full Text] [Related]  

  • 59. Mechanisms to improve chemotherapy effectiveness.
    Young RC
    Cancer; 1990 Feb; 65(3 Suppl):815-22. PubMed ID: 2406004
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined chemotherapy.
    Goldin A
    Oncology; 1980; 37 Suppl 1():3-8. PubMed ID: 7005787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.